These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11834965)

  • 41. Determinants of HIV-related high risk behaviours among young offenders: a window of opportunity.
    Rothon DA; Strathdee SA; Cook D; Cornelisse PG
    Can J Public Health; 1997; 88(1):14-7. PubMed ID: 9094798
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: results of a cohort study.
    Bruneau J; Lamothe F; Franco E; Lachance N; Désy M; Soto J; Vincelette J
    Am J Epidemiol; 1997 Dec; 146(12):994-1002. PubMed ID: 9420522
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Psychiatric, behavioural and social risk factors for HIV infection among female drug users.
    Gilchrist G; Blazquez A; Torrens M
    AIDS Behav; 2011 Nov; 15(8):1834-43. PubMed ID: 21748277
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prescribing syringes to injection drug users with HIV: an important clinical and public health tool.
    Stozek MA; Taylor LE; LeBreux L; Olson J; Wolf F; Rich JD
    J Assoc Nurses AIDS Care; 2004; 15(2):59-63. PubMed ID: 15090134
    [No Abstract]   [Full Text] [Related]  

  • 45. HIV among drug users in China.
    Feng C; Des Jarlais D
    Science; 2002 Nov; 298(5596):1171; author reply 1171. PubMed ID: 12425324
    [No Abstract]   [Full Text] [Related]  

  • 46. HIV transmission among drug users in Larkana, Pakistan.
    ur Rehman N; Emmanuel F; Akhtar S
    Trop Doct; 2007 Jan; 37(1):58-9. PubMed ID: 17326898
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Drug and HIV-related risk behaviors after geographic migration among a cohort of injection drug users.
    Rachlis BS; Wood E; Li K; Hogg RS; Kerr T
    AIDS Behav; 2010 Aug; 14(4):854-61. PubMed ID: 18427970
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High prevalence of HIV risk-behavior and the identification of predictors for sharing injecting materials among young drug users in Prague, Czech Republic.
    Mikl J; Brůcková M; Jedlicka J; Malý M; Vyslouzilová S; Douda I; Minarík J; Smith P; DeHovitz J
    Cent Eur J Public Health; 2001 Nov; 9(4):228-35. PubMed ID: 11787253
    [TBL] [Abstract][Full Text] [Related]  

  • 49. HIV risk behaviors of heterosexual male drug users.
    Needle RH
    NIDA Res Monogr; 1994; 143():5-8. PubMed ID: 8742587
    [No Abstract]   [Full Text] [Related]  

  • 50. HIV risk-related behaviors among injection drug users in Rome: differences between 1990 and 1992.
    Davoli M; Perucci CA; Abeni DD; Arcà M; Brancato G; Forastiere F; Montiroli PM; Zampieri F
    Am J Public Health; 1995 Jun; 85(6):829-32. PubMed ID: 7762718
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Use of latent class analysis approach to describe drug and sexual HIV risk patterns among injection drug users in Houston, Texas.
    Noor SW; Ross MW; Lai D; Risser JM
    AIDS Behav; 2014 Apr; 18 Suppl 3():276-83. PubMed ID: 24510363
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Providers' HIV prevention discussions with HIV-seropositive injection drug users.
    Wilkinson JD; Zhao W; Santibanez S; Arnsten J; Knowlton A; Gómez CA; Metsch LR;
    AIDS Behav; 2006 Nov; 10(6):699-705. PubMed ID: 16639542
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Retrospective cohort study examining incidence of HIV and hepatitis C infection among injecting drug users in Dublin.
    Smyth BP; O'Connor JJ; Barry J; Keenan E
    J Epidemiol Community Health; 2003 Apr; 57(4):310-1. PubMed ID: 12646549
    [No Abstract]   [Full Text] [Related]  

  • 54. A cost-benefit and cost-effectiveness analysis of Vancouver's supervised injection facility.
    Andresen MA; Boyd N
    Int J Drug Policy; 2010 Jan; 21(1):70-6. PubMed ID: 19423324
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevalence and correlates of cervical cancer screening among injection drug users.
    McKnight B; McKnight I; Kerr T; Li K; Montaner J; Wood E
    J Obstet Gynaecol Can; 2006 Aug; 28(8):695-699. PubMed ID: 17022909
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Contextual determinants of drug use risk behavior: a theoretic framework.
    Galea S; Ahern J; Vlahov D
    J Urban Health; 2003 Dec; 80(4 Suppl 3):iii50-8. PubMed ID: 14713671
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Baseline findings from the third collaborative injection drug users study/drug users intervention trial (CIDUS III/DUIT).
    Booth RE; Strathdee SA
    Drug Alcohol Depend; 2007 Nov; 91 Suppl 1():S1-3. PubMed ID: 17889451
    [No Abstract]   [Full Text] [Related]  

  • 58. Vancouver's needle exchange program.
    Bardsley J; Turvey J; Blatherwick J
    Can J Public Health; 1990; 81(1):39-45. PubMed ID: 2311049
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevalence and risk factors for HIV among sniffers, short-term injectors, and long-term injectors of heroin.
    Chitwood DD; Comerford M; Sanchez J
    J Psychoactive Drugs; 2003; 35(4):445-53. PubMed ID: 14986873
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The social course of drug injection and sexual activity among YMSM and other high-risk youth: an agenda for future research.
    Clatts MC; Goldsamt L; Neaigus A; Welle DL
    J Urban Health; 2003 Dec; 80(4 Suppl 3):iii26-39. PubMed ID: 14713669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.